{"pmid":32417899,"title":"Favipiravir, an antiviral for COVID-19?","text":["Favipiravir, an antiviral for COVID-19?","J Antimicrob Chemother","Coomes, Eric A","Haghbayan, Hourmazd","32417899"],"journal":"J Antimicrob Chemother","authors":["Coomes, Eric A","Haghbayan, Hourmazd"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32417899","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/jac/dkaa171","topics":["Treatment"],"weight":1,"_version_":1667058206768103424,"score":9.490897,"similar":[{"pmid":32401463,"title":"Favipiravir","text":["Favipiravir","Favipiravir is an investigational antiviral drug that is being tested for use against the novel coronavirus disease, COVID-19. No information is available on the use of favipiravir during breastfeeding or its excretion into breastmilk. Favipiravir is a small molecule that is about 60% protein bound in plasma, so it would be expected to appear in breastmilk and be absorbed by the infant, probably in small amounts. In clinical trials, favipiravir has been well tolerated, but has caused liver enzyme abnormalities, gastrointestinal symptoms, and serum uric acid elevations.[1-3] If favipiravir is used in a nursing mother, these parameters should be monitored in the breastfed infant.","Drugs and Lactation Database (LactMed)","32401463"],"abstract":["Favipiravir is an investigational antiviral drug that is being tested for use against the novel coronavirus disease, COVID-19. No information is available on the use of favipiravir during breastfeeding or its excretion into breastmilk. Favipiravir is a small molecule that is about 60% protein bound in plasma, so it would be expected to appear in breastmilk and be absorbed by the infant, probably in small amounts. In clinical trials, favipiravir has been well tolerated, but has caused liver enzyme abnormalities, gastrointestinal symptoms, and serum uric acid elevations.[1-3] If favipiravir is used in a nursing mother, these parameters should be monitored in the breastfed infant."],"journal":"Drugs and Lactation Database (LactMed)","date":"2020-05-14T11:01:00Z","year":2006,"_id":"32401463","source":"PubMed","week":"202020|May 11 - May 17","keywords":["favipiravir","avigan","6-fluoro-3-hydroxy-2-pyrazinecarboxamide","t 705","t-705","t705","unii-ew5gl2x7e0","5-fluoro-2-oxo-1h-pyrazine-3-carboxamide","2-pyrazinecarboxamide, 6-fluoro-3-hydroxy-"],"topics":["Treatment"],"weight":1,"_version_":1666714494907187200,"score":43.98191}]}